REFERENCE
Dewilde S, Dale P, Turk F.Cost effectiveness of omalizumab in Swedish asthma patients. European Respiratory Journal Supplement 28 (Suppl. 50): 441s abstr. P2569, Sep 2006
Rights and permissions
About this article
Cite this article
Adding omalizumab to guideline recommended care may be cost effective in patients with severe allergic asthma,. Pharmacoecon. Outcomes News 514, 9 (2006). https://doi.org/10.2165/00151234-200605140-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605140-00022